Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy

PURPOSE: Various radiolabeled prostate-specific membrane antigen (PSMA)–targeting tracers are clinically applied for prostate cancer (PCa) imaging and targeted radionuclide therapy. The PSMA binding affinities, biodistribution, and DNA-damaging capacities of these radiotracers have not yet been comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruigrok, Eline A. M., van Vliet, Nicole, Dalm, Simone U., de Blois, Erik, van Gent, Dik C., Haeck, Joost, de Ridder, Corrina, Stuurman, Debra, Konijnenberg, Mark W., van Weerden, Wytske M., de Jong, Marion, Nonnekens, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113296/
https://www.ncbi.nlm.nih.gov/pubmed/33094433
http://dx.doi.org/10.1007/s00259-020-05057-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113296/
https://www.ncbi.nlm.nih.gov/pubmed/33094433
http://dx.doi.org/10.1007/s00259-020-05057-6

Ejemplares similares